Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
China flag China · Delayed Price · Currency is CNY
12.80
-0.48 (-3.61%)
May 21, 2026, 3:04 PM CST

SHE:300452 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
944.82931.3871.93827.17694.08607.27
Other Revenue
11.4911.4910.6412.0910.449.43
956.32942.8882.57839.26704.53616.71
Revenue Growth (YoY)
7.12%6.82%5.16%19.12%14.24%16.10%
Cost of Revenue
653.28643.94609.34573.93495.28438.93
Gross Profit
303.04298.86273.23265.33209.24177.78
Selling, General & Admin
68.7567.8863.546051.1352.05
Research & Development
40.6142.2740.9541.9534.4326.8
Other Operating Expenses
-0.73-2.51-1.6922.725.85
Operating Expenses
108.62107.64102.8103.9988.2384.7
Operating Income
194.42191.22170.43161.34121.0193.08
Interest Expense
-13.36-13.14-12.73-4.3-1.21-1.2
Interest & Investment Income
17.3614.8920.1811.849.056.93
Currency Exchange Gain (Loss)
-1.06-1.061.880.372.56-0.28
Other Non Operating Income (Expenses)
-2.45-0.47-0.42-0.41-0.38-0.39
EBT Excluding Unusual Items
194.91191.42179.34168.84131.0298.14
Impairment of Goodwill
---39.13---6.13
Gain (Loss) on Sale of Investments
3.335.92-3.138.51-2.621.74
Gain (Loss) on Sale of Assets
-1.07-0.960.11-0.01-0.27-2.96
Asset Writedown
-0.14-0.14-0-1.02-0.01-
Other Unusual Items
2.912.455.179.58.295.89
Pretax Income
199.94198.68142.36185.82136.496.68
Income Tax Expense
25.9525.5121.8321.25.4711.14
Earnings From Continuing Operations
173.99173.17120.52164.62130.9385.54
Minority Interest in Earnings
2.443.38-1.1-3.09-0.233.72
Net Income
176.44176.55119.42161.54130.7189.25
Net Income to Common
176.44176.55119.42161.54130.7189.25
Net Income Growth
51.08%47.84%-26.07%23.58%46.45%-4.99%
Shares Outstanding (Basic)
235235234234233235
Shares Outstanding (Diluted)
242242234241233235
Shares Change (YoY)
2.01%3.28%-2.88%3.29%-0.63%1.93%
EPS (Basic)
0.750.750.510.690.560.38
EPS (Diluted)
0.730.730.510.670.560.38
EPS Growth
48.10%43.14%-23.88%19.64%47.37%-6.79%
Free Cash Flow
169.27151.2690.3977.3865.572.35
Free Cash Flow Per Share
0.700.630.390.320.280.31
Dividend Per Share
0.3000.3000.3000.2500.2500.231
Dividend Growth
--20.00%-8.32%20.02%
Gross Margin
31.69%31.70%30.96%31.61%29.70%28.83%
Operating Margin
20.33%20.28%19.31%19.22%17.18%15.09%
Profit Margin
18.45%18.73%13.53%19.25%18.55%14.47%
Free Cash Flow Margin
17.70%16.04%10.24%9.22%9.30%11.73%
EBITDA
-244.56221.18200.12157.07127.77
EBITDA Margin
-25.94%25.06%23.84%22.30%20.72%
D&A For EBITDA
-53.3450.7538.7836.0634.68
EBIT
194.42191.22170.43161.34121.0193.08
EBIT Margin
20.33%20.28%19.31%19.22%17.18%15.09%
Effective Tax Rate
12.98%12.84%15.33%11.41%4.01%11.53%
Revenue as Reported
956.32942.8882.57839.26704.53616.71
Advertising Expenses
-0.80.970.860.640.44
Source: S&P Global Market Intelligence. Standard template. Financial Sources.